Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$6.23 - $11.12 $66,536 - $118,761
-10,680 Reduced 99.91%
10 $0
Q1 2022

May 13, 2022

SELL
$7.89 - $12.48 $94,332 - $149,210
-11,956 Reduced 52.8%
10,690 $101,000
Q4 2021

Feb 14, 2022

BUY
$9.82 - $12.44 $221,774 - $280,944
22,584 Added 36425.81%
22,646 $262,000
Q3 2021

Nov 15, 2021

SELL
$8.74 - $11.84 $23,729 - $32,145
-2,715 Reduced 97.77%
62 $1,000
Q2 2021

Aug 16, 2021

BUY
$8.71 - $10.72 $24,100 - $29,662
2,767 Added 27670.0%
2,777 $27,000
Q1 2021

May 17, 2021

SELL
$9.2 - $23.86 $12.4 Million - $32.2 Million
-1,350,600 Reduced 100.0%
10 $0
Q4 2020

Feb 17, 2021

BUY
$13.47 - $24.89 $17.5 Million - $32.3 Million
1,299,220 Added 2528.16%
1,350,610 $31.2 Million
Q3 2020

Nov 12, 2020

SELL
$12.89 - $15.89 $4.31 Million - $5.32 Million
-334,610 Reduced 86.69%
51,390 $726,000
Q2 2020

Aug 14, 2020

BUY
$8.86 - $15.69 $3.42 Million - $6.06 Million
386,000 New
386,000 $5.82 Million
Q3 2019

Nov 12, 2019

SELL
$8.02 - $13.25 $5.67 Million - $9.38 Million
-707,600 Closed
0 $0
Q2 2019

Aug 12, 2019

BUY
$10.96 - $14.4 $7.76 Million - $10.2 Million
707,600 New
707,600 $8.83 Million
Q4 2018

Feb 06, 2019

SELL
$8.38 - $13.44 $2.23 Million - $3.58 Million
-266,600 Closed
0 $0
Q3 2018

Nov 09, 2018

BUY
$11.6 - $16.54 $3.09 Million - $4.41 Million
266,600 New
266,600 $3.22 Million
Q3 2017

Oct 30, 2017

SELL
$11.74 - $15.78 $147,924 - $198,828
-12,600 Closed
0 $0
Q2 2017

Jan 31, 2018

SELL
N/A
-1,017,700 Reduced 98.78%
12,600 $127,000
Q1 2017

Jan 31, 2018

BUY
N/A
1,030,300
1,030,300 $7.35 Million

Others Institutions Holding FOLD

About AMICUS THERAPEUTICS, INC.


  • Ticker FOLD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 280,497,984
  • Market Cap $2.53B
  • Description
  • Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...
More about FOLD
Track This Portfolio

Track Canada Pension Plan Investment Board Portfolio

Follow Canada Pension Plan Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Canada Pension Plan Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on Canada Pension Plan Investment Board with notifications on news.